Cancer Res (2024) 84 (7_Supplement): LB055.

Cancer Res (2024) 84 (6_Supplement): 48. Introduction: Multiple Myeloma (MM) is the second most diagnosed hematologic malignancy and remains an incurable disease. KLN-1010 is a novel treatment for MM ...

1Department of Oncology, University of Lausanne, Lausanne, Switzerland.

Institute of TCM-X/MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist/Department of Automation, Tsinghua University, Beijing, China.

1Adult Stem Cell Research Center and Research Institute for Veterinary Science, Seoul, Republic of Korea.

1Department of Biological Sciences, New York City College of Technology, City University of New York, Brooklyn, New York. 2Biology and Computer PhD Programs, The CUNY Graduate Center, City University ...

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, ...

1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.

Abstract. Binding of steroid hormones to their cognate receptors regulates the growth of most prostate and breast cancers. We hypothesized that CYP11A inhibition might halt the synthesis of all ...

1Yonsei University, College of Medicine, Seoul, Republic of Korea.

1Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany. 2Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, ...

Abstract. Macrophages are a type of immune cell that play a crucial role in the tumor microenvironment. In tumors, macrophages can be polarized towards a pro-inflammatory phenotype, referred to as M1, ...